Psychedelic Therapy & Integration

Discover how somatic therapy in psychedelic integration supports healing, self-awareness, and trauma release, enhancing therapeutic journeys.

This webpage presents 'Embodied Psychedelic Therapy: A Somatic Guide' by Manuela Mischke Reeds, exploring the integration of somatic practices with psychedelic therapy. It aims to provide insights into therapeutic approaches that emphasize body awareness and emotional healing.

Preliminary evidence suggests that psychedelic-assisted therapy—the enhancement of psychotherapy with psychedelics such as 3,4-methylenedioxymethamphet-amine (MDMA) and psilocybin—may be efficacious for depression, posttraumatic stress disorder, substance use disorders, and other conditions. Therapeutic psychedelic research is advancing steadily, with psilocybin, MDMA, and lysergic acid diethylamide designated breakthrough therapies by the US Food and Drug Administration (FDA).

This article discusses the integration of psychedelic-assisted therapies, such as MDMA and psilocybin, into routine clinical practice. It highlights lessons learned from implementation science to enhance the therapeutic potential of these substances when used alongside psychotherapy.

The concept of integration has garnered increased attention in the past few years, despite a long history of only brief mention. Integration services are offered by therapists, coaches, and other practitioners to help individuals process their psychedelic experiences.